Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

NCT00142103

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Pfizer Investigational Site Miami, Florida, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Indianapolis, Indiana, United States
  • Pfizer Investigational Site Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Australian Trial in Acute Hepatitis C

NCT00192569

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • 407 Doctors Darlinghurst, New South Wales, Australia
  • Holdsworth House GP Practice Darlinghurst, New South Wales, Australia
  • Kirketon Road Centre Darlinghurst, New South Wales, Australia
View all 18 locations
View Trial Details
Completed

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

NCT00036608

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Investigator Birmingham, Alabama, United States
  • Local Investigator Tucson, Arizona, United States
  • Local Investigator La Jolla, California, United States
  • Local Investigator Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

NCT00035633

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Investigator Birmingham, Alabama, United States
  • Local Investigator Tucson, Arizona, United States
  • Local Investigator La Jolla, California, United States
  • Local Investigator Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

NCT00051038

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Local Institution New Haven, Connecticut, United States
  • Local Institution Altamonte Springs, Florida, United States
  • Local Institution Lousiville, Kentucky, United States
  • Local Institution Charlotte, North Carolina, United States
View Trial Details
Completed

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

NCT00035789

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Local Investigator Birmingham, Alabama, United States
  • Local Investigator Tucson, Arizona, United States
  • Local Investigator La Jolla, California, United States
  • Local Investigator Los Angeles, California, United States
View all 31 locations
View Trial Details

Related conditions